Intellipharmaceutics International Inc.
IPCIQ
$0.00
$0.000.00%
OTC PK
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 20.13% | 68.02% | 53.60% | 43.78% | 17.41% |
| Total Depreciation and Amortization | -14.20% | -14.64% | -14.99% | -15.35% | -27.50% |
| Total Amortization of Deferred Charges | -962.50% | -962.50% | -962.50% | -975.00% | -48.39% |
| Total Other Non-Cash Items | 315.53% | 60.61% | -95.65% | -104.73% | -86.47% |
| Change in Net Operating Assets | 24.10% | -73.08% | 32.21% | -5.45% | 145.87% |
| Cash from Operations | 107.88% | 84.08% | 72.15% | 43.60% | 44.28% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -- | -- | 2,350.98% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -100.00% | -- | -- | 2,350.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -- | -- | -93.40% | -93.40% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.16% | 89.82% | -1,729.89% | -220.76% | -432.50% |